Zimmer Partners LP Takes $19.84 Million Position in American Healthcare REIT, Inc. (NYSE:AHR)

Zimmer Partners LP acquired a new stake in shares of American Healthcare REIT, Inc. (NYSE:AHR) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 760,000 shares of the company’s stock, valued at approximately $19,836,000. Zimmer Partners LP owned about 0.58% of American Healthcare REIT as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in AHR. Vanguard Group Inc. purchased a new position in shares of American Healthcare REIT during the first quarter valued at approximately $16,205,000. CWM LLC bought a new stake in American Healthcare REIT during the second quarter valued at approximately $58,000. Manning & Napier Advisors LLC bought a new stake in American Healthcare REIT during the second quarter valued at approximately $3,317,000. SG Americas Securities LLC bought a new stake in American Healthcare REIT during the second quarter valued at approximately $189,000. Finally, Peak Financial Advisors LLC grew its position in American Healthcare REIT by 10.4% during the second quarter. Peak Financial Advisors LLC now owns 31,126 shares of the company’s stock valued at $455,000 after buying an additional 2,921 shares during the period. 16.68% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on AHR. Truist Financial boosted their target price on shares of American Healthcare REIT from $27.00 to $29.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Morgan Stanley boosted their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Colliers Securities upgraded shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. Royal Bank of Canada upped their price target on shares of American Healthcare REIT from $28.00 to $30.00 and gave the stock an “outperform” rating in a research report on Monday, November 18th. Finally, JMP Securities upped their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, September 20th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $25.13.

American Healthcare REIT Trading Down 1.0 %

AHR stock opened at $28.55 on Friday. American Healthcare REIT, Inc. has a one year low of $12.63 and a one year high of $29.99. The company’s fifty day moving average price is $26.54 and its 200-day moving average price is $20.88. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37.

American Healthcare REIT (NYSE:AHR) last released its earnings results on Tuesday, November 12th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.32 by ($0.35). The company had revenue of $523.81 million during the quarter, compared to analysts’ expectations of $474.26 million. American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. American Healthcare REIT’s revenue was up 12.8% compared to the same quarter last year. Research analysts forecast that American Healthcare REIT, Inc. will post 1.42 EPS for the current year.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.